Pathology and Lab Medicine
499
Episodes 33-37 of 37
- CME/CE Broadcast Replay
Understanding the Biological and Clinical Rationale for PARP Inhibitor Combinations as Potential Treatment for Prostate Cancer
1.00 creditNeeraj Agarwal, MD, FASCO
Jacob Sands, MD
Lori Pierce, MD, FASTRO, FASCO
John Russell, MD
Meredith Wadman, BM, BCh, M.S.
Matt Birnholz, MD
- Clinician's Roundtable
Combatting Pancreatic Cancer: Keys to Early Recognition and Diagnosis
Ana Maria Rosario
- Previous
- Next